KWALITY PHARMACEUTICALS
Back to Balance Sheet
|
KWALITY PHARMACEUTICALS Last 5 Year Total Non-Current Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Non-Current Liabilities | ₹14 Cr | ₹20 Cr | ₹29 Cr | ₹21 Cr | ₹28 Cr |
What is the latest Total Non-Current Liabilities ratio of KWALITY PHARMACEUTICALS ?
| Year | Total Non-Current Liabilities |
|---|---|
| Mar2025 | ₹14 Cr |
| Mar2024 | ₹20 Cr |
| Mar2023 | ₹29 Cr |
| Mar2022 | ₹21 Cr |
| Mar2021 | ₹28 Cr |
How is Total Non-Current Liabilities of KWALITY PHARMACEUTICALS Trending?
| Years | Total Non-Current Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹14 Cr | -30.35 | |
| Mar2024 | ₹20 Cr | -30.98 | |
| Mar2023 | ₹29 Cr | 34.25 | |
| Mar2022 | ₹21 Cr | -24.10 | |
| Mar2021 | ₹28 Cr | - | |
Compare Total Non-Current Liabilities of peers of KWALITY PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| KWALITY PHARMACEUTICALS | ₹1,095.4 Cr | -1.9% | -9.3% | 23.2% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹393,323.0 Cr | 1.7% | -5.7% | -7.4% | Stock Analytics | |
| DIVIS LABORATORIES | ₹160,825.0 Cr | 0.8% | -6.7% | 3.2% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹135,349.0 Cr | 0.6% | 4.3% | 24.4% | Stock Analytics | |
| CIPLA | ₹106,048.0 Cr | -4.7% | -12.3% | -7.9% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹103,494.0 Cr | 6.3% | -2.1% | -4.1% | Stock Analytics | |
KWALITY PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| KWALITY PHARMACEUTICALS | -1.9% |
-9.3% |
23.2% |
| SENSEX | -1.7% |
-4.3% |
6.2% |
You may also like the below Video Courses